influenza virus vaccine, monovalent a/h3n2v a/minnesota/11/2010 nymc x-203
Vaccineexperimental
Clinical trial activity
2 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Jun 11, 2014 (NCT02100436)
Timeline
2010s
- Jan 1, 2014
Earliest Phase 2 Sponsor(trial)
Indications
Mechanism of action
- Influenza A virusImmunity, active
Influenza A virus immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- influenza virus vaccine, monovalent a/h3n2v a/minnesota/11/2010 nymc x-203
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02921997 | Phase 2 | Nov 7, 2016 | National Institute of Allergy and Infectious Diseases (NIAID) |
| NCT02100436 | Phase 2 | Jun 11, 2014 | National Institute of Allergy and Infectious Diseases (NIAID) |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| National Institute of Allergy and Infectious Diseases (NIAID) | Government | 2 | 2 | 1 | 2014 |
1 organizations
Page 1 / 1